@article {1498252,
	title = {Diabetic retinopathy and ultrawide field imaging},
	journal = {Semin Ophthalmol},
	volume = {35},
	number = {1},
	year = {2020},
	month = {2020 Jan 02},
	pages = {56-65},
	abstract = {The introduction of ultrawide field imaging has allowed the visualization of approximately 82\% of the total retinal area compared to only 30\% using 7-standard field Early Treatment Diabetic Retinopathy (ETDRS) photography. This substantially wider field of view, while useful in many retinal vascular diseases, is particularly important in diabetic retinopathy where eyes with predominantly peripheral lesions or PPL have been shown to have significantly greater progression rates compared to eyes without PPL. In telemedicine settings, ultrawide field imaging has substantially reduced image ungradable rates and increased rate of disease identification allowing care to be delivered more effectively. Furthermore, the use of ultrawide field fluorescein angiography allows the visualization of significantly more diabetic retinal lesions and allows more accurate quantification of total retinal nonperfusion, with potential implications in the management of diabetic retinopathy and diabetic macular edema. The focus of this paper is to review the current role of ultrawide field imaging in diabetic retinopathy and its possible future role in innovations for retinal image analysis such as artificial intelligence and vessel caliber measurements.},
	issn = {1744-5205},
	doi = {10.1080/08820538.2020.1729818},
	author = {Ashraf, Mohamed and Shokrollahi, Siamak and Salongcay, Recivall P and Aiello, Lloyd Paul and Silva, Paolo S}
}
